Legg Mason Asset Management’s Vertex Pharmaceuticals VRTX Stock Holding History

Legg Mason Asset Management’s Portfolio VRTX Stock Details VRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	$774K	Buy	3,525 +516	+17%	+$100K	0.86%	53
2021 Q3	$546K	Sell	3,009 -249	-8%	-$48.6K	0.63%	85
2021 Q2	$657K	Sell	3,258 -291	-8%	-$60.9K	0.72%	80
2021 Q1	$763K	Buy	3,549 +189	+6%	+$41.5K	0.83%	58
2020 Q4	$794K	Buy	+3,360	New	+$771K	0.79%	53
2020 Q2	$426K	Buy	+1,465	New	+$397K	0.47%	100

Other funds holding VRTX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Legg Mason Asset Management's VRTX Position: Q4 2021 in Review

Legg Mason Asset Management increased its Vertex Pharmaceuticals (VRTX) stake by 17% in Q4 2021, buying an estimated $100K and bringing the position to 3,525 shares worth $774K. The position accounts for 0.86% of the portfolio, ranked #53.

Legg Mason Asset Management first reported a position in VRTX in Q2 2020 and has held it in 6 quarters since. The position peaked at $794K in Q4 2020. 1,033 funds tracked by Wall St. Rank hold VRTX as of Q4 2021.

Legg Mason Asset Management held 3,525 shares of Vertex Pharmaceuticals worth $774K as of Q4 2021.
Legg Mason Asset Management bought 516 Vertex Pharmaceuticals shares in Q4 2021, an estimated $100K.
Vertex Pharmaceuticals made up 0.86% of Legg Mason Asset Management's portfolio in Q4 2021, its #53 holding.
Legg Mason Asset Management first reported a position in Vertex Pharmaceuticals in Q2 2020 and has held it in 6 quarters since.
Legg Mason Asset Management's Vertex Pharmaceuticals position peaked at $794K in Q4 2020.
1,033 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q4 2021.

Based on Legg Mason Asset Management's 13F filing for Q4 2021, filed 14 Feb 2022.